Oncolytics Biotech (ONCY)

• Market cap: $42.3M
• 1 day: -7.13%
• 5 days: -5.48%
• 1 month: -23.68%
• 3 months: -43.55%
• 6 months: -61.42%
• Year to date: -47.30%
• 1 year: -57.76%
• 5 years: -66.21%
• 10 years: -33.89%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

10% more capital invested

Capital invested by funds: $1.1M [Q3] → $1.21M (+$107K) [Q4]

10% more funds holding

Funds holding: 42 [Q3] → 46 (+4) [Q4]

0.15% more ownership

Funds ownership: 1.55% [Q3] → 1.71% (+0.15%) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $3 512% upside
• Avg. target: $4.33 784% upside
• High target: $5 920% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Jason McCarthy 15% 1-year accuracy 5 / 33 met price target	512% upside $3	Buy Maintained	10 Mar 2025
HC Wainwright & Co. Patrick Trucchio 12% 1-year accuracy 22 / 187 met price target	920% upside $5	Buy Reiterated	10 Mar 2025
RBC Capital Douglas Miehm 44% 1-year accuracy 11 / 25 met price target	920% upside $5	Outperform Maintained	10 Mar 2025